Use of a receptor-type kinase modulator for treating polycystic kidney disease
View Patent ↗The invention comprises use of a therapeutically effective amount of the compound of the formula below for preparation of a medicament for treating polycystic kidney diseases (PKD) in a mammal, such as human or feline (e.g., Persian cat). Formula (I). Also provided are the above compound and compositions comprising it for treating PKD.
1. A method of treating polycystic kidney disease (PKD) in a mammal, the method comprising administering a therapeutically effective amount of a compound of formula
or a pharmaceutically acceptable salt thereof, to a mammal having PKD.
2. The method of claim 1 wherein the mammal is a human.
3. The method of claim 1 wherein the mammal is a feline.
4. The method of claim 3 wherein the feline is a Persian cat.
5. The method of claim 1 where the compound is delivered in the form of a pharmaceutical composition comprising the compound or a salt thereof and a pharmaceutically acceptable carrier, excipient, and/or diluent.
6. The method of claim 2 where the compound is delivered in the form of a pharmaceutical composition comprising the compound or a salt thereof and a pharmaceutically acceptable carrier, excipient, and/or diluent.
7. The method of claim 3 where the compound is delivered in the form of a pharmaceutical composition comprising the compound or a salt thereof and a pharmaceutically acceptable carrier, excipient, and/or diluent.
8. The method of claim 4 where the compound is delivered in the form of a pharmaceutical composition comprising the compound or a salt thereof and a pharmaceutically acceptable carrier, excipient, and/or diluent.